pyridoxamine has been researched along with Hyperlipemia in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "PM inhibited AGE/ALE formation and hyperlipidemia and protected against renal and vascular pathology in a nondiabetic model." | 1.32 | The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. ( Alderson, NL; Baynes, JW; Beattie, RJ; Chachich, ME; Nachtigal, M; Thorpe, SR; Youssef, NN, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alderson, NL | 3 |
| Chachich, ME | 2 |
| Youssef, NN | 1 |
| Beattie, RJ | 2 |
| Nachtigal, M | 1 |
| Thorpe, SR | 3 |
| Baynes, JW | 3 |
| Metz, TO | 1 |
| Degenhardt, TP | 1 |
| Arrington, DD | 1 |
| Basgen, JM | 1 |
| Steffes, MW | 1 |
3 other studies available for pyridoxamine and Hyperlipemia
| Article | Year |
|---|---|
The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats.
Topics: Animals; Aorta; Arginine; Blood Glucose; Blood Pressure; Collagen; Female; Glycation End Products, A | 2003 |
Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications.
Topics: Animals; Arachidonic Acid; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Fatty Acids, Un | 2003 |
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
Topics: Animals; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fem | 2002 |